Kazia Therapeutics (KZIA) Non-Current Assets (2009 - 2025)

Kazia Therapeutics has reported Non-Current Assets for 15 years, with the latest figure at $739642.8 in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets fell 92.2% year-over-year to $739642.8; the trailing twelve-month figure through Dec 2025 stood at $739642.8 (down 92.2% YoY), and the FY2025 full-year result was $721458.3, down 92.91% from the prior year.
• Non-Current Assets for Q4 2025 stood at $739642.8, up from $721458.3 in the prior quarter.
• The five-year high for Non-Current Assets was $22.1 million in Q2 2021, with the low at $721458.3 in Q2 2025.
• Historically, Non-Current Assets has averaged $11.9 million across 5 years, with a median of $11.1 million in 2023.
• Annual changes were most pronounced in 2021 — Non-Current Assets surged 171.69% — and 2025, when it slumped 92.91%.
• Kazia Therapeutics' Non-Current Assets stood at $20.4 million in 2021, then decreased by 29.3% to $14.4 million in 2022, then fell by 25.98% to $10.7 million in 2023, then decreased by 11.01% to $9.5 million in 2024, then tumbled by 92.2% to $739642.8 in 2025.
• The last three Non-Current Assets figures came in at $739642.8 (Q4 2025), $721458.3 (Q2 2025), and $9.5 million (Q4 2024), per Business Quant data.